首页> 美国卫生研究院文献>Gut and Liver >Efficacy of Capecitabine Plus Oxaliplatin Combination Chemotherapy for Advanced Pancreatic Cancer after Failure of First-Line Gemcitabine-Based Therapy

【2h】

Efficacy of Capecitabine Plus Oxaliplatin Combination Chemotherapy for Advanced Pancreatic Cancer after Failure of First-Line Gemcitabine-Based Therapy

机译：卡培他滨联合奥沙利铂联合化疗在基于吉西他滨一线治疗失败的晚期胰腺癌中的疗效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background/AimsSecond-line chemotherapy in patients with advanced pancreatic ductal adenocarcinoma (PDAC) that progresses following gemcitabine-based treatment has not been established. This study aimed to investigate the efficacy and safety of second-line combination chemotherapy with capecitabine and oxaliplatin (XELOX) in these patients.

机译：背景/目的尚未建立在吉西他滨为基础的治疗后进展的晚期胰腺导管腺癌（PDAC）患者中的二线化疗。这项研究旨在研究卡培他滨和奥沙利铂（XELOX）二线联合化疗在这些患者中的疗效和安全性。

著录项

期刊名称 Gut and Liver
作者
Kwang Hyun Chung; Ji Kon Ryu; Jun Hyuk Son; Jae Woo Lee; Dong Kee Jang; Sang Hyub Lee; Yong-Tae Kim;
展开▼
作者单位

展开▼
年(卷),期 2017(11),2
年度 2017
页码 298–305
总页数 8
原文格式 PDF
正文语种
中图分类肠道病毒与肝炎病毒;肝及胆疾病;肠疾病;
关键词
Carcinoma pancreatic ductal Treatment outcome Capecitabine Oxaliplatin Salvage therapy;

机译：癌;胰管;治疗结果;卡培他滨;奥沙利铂;挽救疗法;

相似文献

外文文献
中文文献
专利

1. A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer [J] . ChaoY., HsiehJ.-S., YehH.-T., Cancer chemotherapy and pharmacology. . 2014,第4期

机译：多中心卡培他滨联合奥沙利铂作为一线化疗的多中心II期研究，用于局部晚期或转移性胃癌患者
2. A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer [J] . ChaoY., HsiehJ.-S., YehH.-T., Cancer chemotherapy and pharmacology. . 2014,第4期

机译：双周二十次杂志三合一与奥沙利铂相结合的多中心研究，作为局部晚期或转移性胃癌患者的一线化学疗法
3. Comparing the Efficacy of Nab-paclitaxel Plus S-1 With Gemcitabine-based Chemotherapy as First-line Strategy for Advanced Pancreatic Cancer [J] . Deng G. C., Guan S. S., Yan H., Pancreas . 2019,第10期

机译：将Nab-PACLITAXEL PLUS S-1与基于吉西他滨的化疗的疗效进行比较，作为晚期胰腺癌的一线策略
4. Efficacy of combination chemotherapy with docetaxel and irinotecan as first- or second-line treatment for advanced gastric cancer [C] . K. Sugiyama, A. Ishikawa, T. Watanabe International Gastric Cancer Congress . 2009

机译：组合化疗与多西紫杉醇和伊替康的疗效，作为晚期胃癌的第一或二线治疗
5. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [D] . 鈴木, 裕子 2019

机译：吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
6. A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer [O] . Yee Chao, Jan-Sing Hsieh, Hsien-Tang Yeh, -1

机译：多中心卡培他滨联合奥沙利铂为一线化疗的多中心II期研究用于局部晚期或转移性胃癌患者
7. A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer [O] . Yee Chao, Jan-Sing Hsieh, Hsien-Tang Yeh, 2014

机译：多中心卡培他滨联合奥沙利铂作为一线化疗的多中心II期研究，用于局部晚期或转移性胃癌患者

Efficacy of Capecitabine Plus Oxaliplatin Combination Chemotherapy for Advanced Pancreatic Cancer after Failure of First-Line Gemcitabine-Based Therapy

摘要

著录项

相似文献

相关主题

期刊订阅